Company intelligence / Profile preview

ACS

Villeurbanne, Auvergne-Rhône-Alpes, France

Ownership: Private
Employees: ~15
Development stage: Other

Overview

ACS Biotech is a French regenerative medicine company dedicated to developing innovative solutions for osteoarticular tissue repair. The company's core technology is a patented 3D hydrogel chitosan matrix that facilitates the regeneration of articular cartilage through a minimally invasive, single-injection procedure. Its lead product, a cell-based cartilage gel, is currently in the pre-clinical stage with plans for upcoming clinical trials. Beyond its therapeutic pipeline, ACS Biotech commercializes its 3D matrix for advanced cell culture and operates a specialized osteoarticular biobank to support global R&D in orthopedics and tissue engineering.

Therapeutic areas: Rheumatology
Modalities: Cell therapyHydrogel-based drug delivery therapyBiologicAdvanced Therapy Medicinal Product
Industry: Biotech

Partnerships

Clinique du Parc LyonCNRSClaude Bernard University Lyon 1MabDesignFranceBioLead

Beyond the preview

Go deeper on ACS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ACS.

Explore the full profile